Relation Between Body Mass Index and Endometrial Thickness

Postmenopausal Bleeding Clinical Trial

Official title:

The Relationship Between Transvaginal Ultrasound Endometrial Thickness and Body Mass Index and Pathology in Postmenopausal Bleeding

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03841916
• Other study ID #: Body mass index
• Status: Recruiting
• Start date: December 2, 2018
• Est. completion date: March 20, 2019

Study information

• Verified date: March 2019
• Source: Aljazeera Hospital
• Contact: Mahmoud Alalfy, PhD
• Phone: 01002611058
• Email: mahmoudalalfy[@]ymail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Postmenopausal Bleeding (PMB) is defined as recurrent attacks of bleeding occurring in women after menopause one year at least after stoppage of cycles [

Description:

Premalignant lesions and malignant lesions most commonly complex hyperplasia with atypia and carcinoma of the endometrium are present in 1/3 of patients evaluated for postmenopausal bleed-ing, and so investigations for cases of postmeno-pausal bleeding are mandatory

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 200
• Est. completion date: March 20, 2019
• Est. primary completion date: March 6, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 45 Years to 75 Years

Eligibility

Inclusion Criteria:

• menopausal women (defined as minimum of 1 year of amenorrhea after the age of 45 years if only the amenorrhea is not related to pregnancy, medication or disease),

Exclusion Criteria:

• Women with chronic diseases as diabetes mellitus, hypertension or hematological disorders, those received hormone replacement therapy, Tamoxifen or anticoagulant therapy and women with adnexal massed detected by TVUS or apparent causes of bleeding from cervix or vagina e.g. ulcer were excluded.

Related Conditions & MeSH terms

• Hemorrhage
• Postmenopausal Bleeding
• Uterine Hemorrhage

Intervention

Diagnostic Test:
• transvaginal ultrasound
transvaginal ultrasound to measure endometrial thickness

Locations

Country	Name	City	State
Egypt	Algazeerah and Kasralainy hospital	Giza

Sponsors (2)

Lead Sponsor	Collaborator
Aljazeera Hospital	Kasr El Aini Hospital

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	the number of women who will have a relation between endometrial thickness and BMI	if there is a relation between increased BMI and endometrial thickness	within 2 weeks